New groups for basic research in the Campus ICO-Germans Trias i Pujol Research of the Josep Carreras Leukaemia Research Institute

New groups for basic research in the Campus ICO-Germans Trias i Pujol Research of the Josep Carreras Leukaemia Research Institute 

Starting this February, two new basic research teams lead by researchers Dr Marcus Bushbeck and Dr Fumiichiro Yamamoto have joined the ICO-Germans Trias I Pujol Campus of the Josep Carreras Leukaemia Research Institute.

Among others, Dr Yamamoto focuses his research on the role of blood types in different clinical situations. Dr Yamamoto, who received his doctorate at the Osaka City University (Japan), has dedicated the better part of his career to the study of the molecular basis of ABO blood types. After joining the IJC, Dr Yamamoto will redirect his expertise in this field and in the field of glycobiology towards the study of malignant haemopaties. Dr Yamamoto has received many prizes and is known around the world for his research in the essential field of biology of blood.

On the other hand, Dr Bushbeck focuses his research on the study of chromatin, the complex combination of protein and DNA structures in cells. Going into further study of chromatin is basic to understanding normal or abnormal cell growth and their development. 

Dr Bushbeck was born in Frankfurt (Germany) and has studied chromatin biology in many institutions such as Oxford University, the Max Planck Institute of Biochemistry, the Barcelona Centre for Genomic Regulation or the Institute of Predictive and Personalized Medicine of Cancer. At the IJC, Dr Bushbeck’s team will study the structure of chromatin, its genetic material and the normal chemical intracellular processes that can cause some cells to become leukaemic, with stopping it from happening as a goal.

+ info on Dr Fumiichiro Yamamoto’s “Immunohematology and Glycobiology” research line 

+ info  on Dr Marcus Buschbeck’s “Chromatin, Metabolism and Cell Fate” research line

Webpage updated 08/12/2016 12:12:47